4.6 Review

Emerging Role of Glioma Stem Cells in Mechanisms of Therapy Resistance

Related references

Note: Only part of the references are listed.
Article Developmental Biology

WDR5 represents a therapeutically exploitable target for cancer stem cells in glioblastoma

Kelly Mitchell et al.

GENES & DEVELOPMENT (2023)

Article Oncology

USP36 promotes tumorigenesis and drug sensitivity of glioblastoma by deubiquitinating and stabilizing ALKBH5

Guoqiang Chang et al.

Summary: This study reveals that USP36, as a deubiquitinating enzyme (DUB), plays a crucial role in stabilizing ALKBH5 and regulating ALKBH5-mediated gene expression in glioblastoma. The depletion of USP36 impairs cell proliferation, self-renewal of GSCs, and sensitizes GSCs to treatment, indicating its potential as a therapeutic target for glioblastoma.

NEURO-ONCOLOGY (2023)

Article Medicine, Research & Experimental

Immune checkpoint blockade in glioblastoma from tumor heterogeneity to personalized treatment

Victor A. Arrieta et al.

Summary: Immune checkpoint blockade (ICB) has revolutionized modern cancer therapy, arousing great interest in the neuro-oncology community. While several reports show that subsets of patients with glioma exhibit durable responses to immunotherapy, the efficacy of this treatment has not been observed for unselected patient populations, preventing its broad clinical implementation for gliomas and glioblastoma (GBM).

JOURNAL OF CLINICAL INVESTIGATION (2023)

Review Endocrinology & Metabolism

Unexplored Functions of Sex Hormones in Glioblastoma Cancer Stem Cells

Juyeun Lee et al.

Summary: Biological sex impacts organismal development and disease trajectory. In glioblastoma (GBM), there is a male bias in incidence and outcome, and key genetic and epigenetic differences, as well as differences in immune response, have been revealed. Understanding the contribution of sex hormones vs sex chromosomes to CSC function is important for exploring new treatment strategies.

ENDOCRINOLOGY (2022)

Article Oncology

Surgical resection of glioblastomas induces pleiotrophin-mediated self-renewal of glioblastoma stem cells in recurrent tumors

Arnon Moldrup Knudsen et al.

Summary: Surgical tumor resection induces infiltration of microglia/macrophages and elevated expression of pleiotrophin (PTN) in recurrent glioblastoma tumors, promoting therapeutic resistance and tumor recurrence.

NEURO-ONCOLOGY (2022)

Article Oncology

Transcription Elongation Machinery Is a Druggable Dependency and Potentiates Immunotherapy in Glioblastoma Stem Cells

Zhixin Qiu et al.

Summary: This study identifies the YY1-CDK9 transcription elongation complex as a crucial factor in maintaining glioblastoma stemness and therapeutic resistance. Targeting this complex can activate interferon response, reduce regulatory T-cell infiltration, and enhance the efficacy of immune checkpoint therapy.

CANCER DISCOVERY (2022)

Article Oncology

Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoter

Michael Lim et al.

Summary: The study evaluated the addition of the immune checkpoint inhibitor nivolumab (NIVO) to radiotherapy (RT) + temozolomide (TMZ) in newly diagnosed glioblastoma patients and found that it did not improve survival in these patients.

NEURO-ONCOLOGY (2022)

Review Biochemistry & Molecular Biology

Targeting Glioblastoma Stem Cells to Overcome Chemoresistance: An Overview of Current Therapeutic Strategies

Hyunkoo Kang et al.

Summary: Glioblastoma (GBM) is a highly malignant brain tumor that is resistant to current therapies. This review focuses on the resistance mechanisms of GBM, particularly towards temozolomide (TMZ), and summarizes the recent findings on the intrinsic and extrinsic mechanisms of chemoresistance in GBM stem cells (GSCs). It also discusses novel therapeutic strategies, such as molecular targeting, autophagy inhibition, oncolytic viral therapy, drug repositioning, and targeting of GSC niches, to eliminate GSCs and improve GBM therapy.

BIOMEDICINES (2022)

Article Oncology

Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma

Vidhya M. Ravi et al.

Summary: This study utilizes spatially resolved transcriptomics, metabolomics, and proteomics to characterize glioblastomas and uncover their spatial organization and adaptive mechanisms to inflammatory and metabolic stimuli. The integration of metabolic imaging and imaging mass cytometry reveals the interdependence between tumor and host in a locoregional manner, leading to spatially exclusive adaptive transcriptional programs. The findings confirm the importance of environmental stress in shaping glioblastoma subclones and their transcriptional programs.

CANCER CELL (2022)

Article Cell Biology

PDGF signaling inhibits mitophagy in glioblastoma stem cells through N6-methyladenosine

Deguan Lv et al.

Summary: Dysregulated growth factor receptor pathways, RNA modifications, and metabolism each promote tumor heterogeneity. PDGF signaling induces m(6)A accumulation in GBM stem cells to regulate mitophagy. PDGF-METTL3-OPTN signaling is identified as a therapeutic target for GBM treatment.

DEVELOPMENTAL CELL (2022)

Review Immunology

The immunosuppressive microenvironment and immunotherapy in human glioblastoma

Xuehua Zhang et al.

Summary: This review discusses the characteristics of glioblastoma multiforme (GBM) and the impact of the immunosuppressive tumor microenvironment on treatment. It also explores the relationship between the gut microbiota and GBM treatment, as well as the current progress in immunotherapeutic strategies.

FRONTIERS IN IMMUNOLOGY (2022)

Article Oncology

Modeling Therapy-Driven Evolution of Glioblastoma with Patient-Derived Xenografts

Matthew McCord et al.

Summary: This study developed therapy-resistant glioblastoma patient-derived xenografts (PDX) by exposing them to radiation and temozolomide. These PDX models reflect key features of recurrent glioblastoma and can serve as valuable tools for testing new therapies.

CANCERS (2022)

Article Cell Biology

Intracavity generation of glioma stem cell-specific CAR macrophages primes locoregional immunity for postoperative glioblastoma therapy

Chen Chen et al.

Summary: Researchers have developed a cavity-injectable nanoporter-hydrogel superstructure to prevent relapse of glioblastoma multiforme (GBM). This superstructure introduces glioma stem cell-specific chimeric antigen receptor (CAR) genes into macrophages/microglia, stimulating an antitumor immune response and preventing postoperative relapse.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Cell Biology

Characterization of the minimal residual disease state reveals distinct evolutionary trajectories of human glioblastoma

Maleeha A. Qazi et al.

Summary: Recurrence of solid tumors leads to advanced, treatment-resistant disease with distinct mutational and oncogenic landscape. By analyzing tumor stem cell populations, researchers identified different recurrence patterns and found clonal populations can acquire fitness advantage through therapy. Moreover, they discovered an immunomodulatory signature in the MRD state that has prognostic significance in solid cancers.

CELL REPORTS (2022)

Article Medicine, Research & Experimental

ADAR1-mediated RNA editing links ganglioside catabolism to glioblastoma stem cell maintenance

Li Jiang et al.

Summary: This study reveals the role of A-to-I RNA editing mediated by ADAR1 in GBM stem cells and its potential as a therapeutic strategy. The elevated expression of ADAR1 and global RNA editomes in GSCs suggest their involvement in therapeutic resistance and relapse. Inhibition of ADAR1 or the upstream JAK/STAT pathway impairs GSC self-renewal and stemness. Additionally, the study highlights the critical role of RNA editing in ganglioside catabolism and its impact on GSCs.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Immunology

Activation of 4-1BBL+ B cells with CD40 agonism and IFNγ elicits potent immunity against glioblastoma

Catalina Lee-Chang et al.

Summary: The B-Vax vaccine developed in this study showed significant effects in activating autologous CD8(+) T cells and killing GBM cells, achieving an 80% tumor eradication rate in experimental animals.

JOURNAL OF EXPERIMENTAL MEDICINE (2021)

Article Medicine, Research & Experimental

Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells

Sandipan Datta et al.

Summary: GBM tumors contain glioma stem-like cells (GSCs) and differentiated GBM cells (d-GCs) with differences in mitochondrial metabolism. Inhibiting mitochondrial function selectively targets GSCs and may offer a potential therapeutic option for GBM treatment. Further studies are needed to explore the effectiveness of mitochondrial inhibitors as a targeted therapy for GBM.

BIOMEDICINE & PHARMACOTHERAPY (2021)

Article Oncology

CRISPR Screening of CAR T Cells and Cancer Stem Cells Reveals Critical Dependencies for Cell-Based Therapies

Dongrui Wang et al.

Summary: Reciprocal CRISPR screening identified genes in both CAR T cells and tumor cells regulating the potency of CAR T-cell cytotoxicity, informing molecular targeting strategies to potentiate CAR T-cell antitumor efficacy and elucidate genetic modifications of tumor cells in combination with CAR T cells to advance immuno-oncotherapy.

CANCER DISCOVERY (2021)

Article Oncology

Proteogenomic and metabolomic characterization of human glioblastoma

Liang-Bo Wang et al.

Summary: Understanding the molecular pathogenesis of glioblastoma is crucial for improving diagnosis and treatment. Integrated analysis of genomic, proteomic, and metabolomic data on treatment-naive glioblastomas has identified key phosphorylation events and potential targets for specific tumor alterations. Immune subtypes with distinct immune cell types were discovered, and specific histone acetylation patterns were correlated with these subtypes, providing insights for stratification of patients for more effective treatment.

CANCER CELL (2021)

Article Biochemistry & Molecular Biology

PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells

Tianzhi Huang et al.

Summary: This study reveals that a CK2 alpha-PRMT6-RCC1 signaling axis plays a crucial role in the stem-like properties and tumor biology of GSCs, contributing to chromatin condensation, mitosis, and overall malignancy in GBM. EPZ020411, a specific small-molecule inhibitor for PRMT6, shows potential as a therapeutic target for treating GBM by suppressing RCC1 arginine methylation and enhancing the efficacy of radiotherapy against GSC brain tumor xenografts.

MOLECULAR CELL (2021)

Article Multidisciplinary Sciences

Neoadjuvant PD-1 blockade induces T cell and cDC1 activation but fails to overcome the immunosuppressive tumor associated macrophages in recurrent glioblastoma

Alexander H. Lee et al.

Summary: The authors conducted a high-dimensional analysis of the immune landscape in glioblastoma patients following neoadjuvant PD-1 blockade, revealing an increase in T cell infiltration and a population of progenitor exhausted T cells within the tumor. The study also identified changes in dendritic cells and myeloid cells following PD-1 blockade, suggesting the need for targeting these cells in future immunotherapeutic strategies for clinical benefit.

NATURE COMMUNICATIONS (2021)

Review Immunology

Befriending the Hostile Tumor Microenvironment in CAR T-Cell Therapy

Lorenzo Lindo et al.

Summary: CAR T-cell therapy has shown remarkable efficacy in treating B-cell malignancies, but is hindered by local immunosuppression and toxicities such as cytokine release syndrome and neurotoxicity. Armored CAR T-cells and other combinatorial approaches are being explored to improve outcomes, although they may also increase the risk of adverse events.

FRONTIERS IN IMMUNOLOGY (2021)

Review Oncology

The Role of Hypoxia in Glioblastoma Radiotherapy Resistance

Agathe L. Chedeville et al.

Summary: Glioblastoma (GB) is the deadliest type of primary brain tumor with a median survival time of 16 months post-diagnosis, and radiotherapy remains the most effective treatment despite the common resistance observed in GB patients. Understanding the role of low tumor oxygenation (hypoxia) in radioresistance is crucial for developing novel strategies to improve tumor cell sensitivity to radiotherapy.

CANCERS (2021)

Review Cell Biology

The Many Facets of Therapy Resistance and Tumor Recurrence in Glioblastoma

Anshika Goenka et al.

Summary: GBM is the most lethal type of primary brain cancer, with therapy resistance attributed to both intrinsic factors like tumor heterogeneity and altered metabolomics, as well as extrinsic factors like hypoxia and an immune-suppressive tumor microenvironment. The escape mechanisms of tumor cells during therapy also contribute to treatment failure in GBM.

CELLS (2021)

Review Oncology

Beyond the Double-Strand Breaks: The Role of DNA Repair Proteins in Cancer Stem-Cell Regulation

Jacqueline Nathansen et al.

Summary: Cancer stem cells (CSCs) are a highly tumorigenic cell population capable of repopulating tumors and causing relapses even after successful therapy. They possess enhanced DNA repair mechanisms that not only contribute to therapy resistance, but also play crucial roles in tumor evolution and treatment resistance. The role of DNA repair proteins in CSCs extends beyond DNA repair, impacting transcription regulation, signaling pathways, cellular stress responses, and immune reactions towards tumor cells. Targeting DNA repair pathways in CSCs holds promise for personalized therapies and sensitizing CSCs to anti-cancer treatments.

CANCERS (2021)

Article Cell Biology

SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastoma

Joseph H. Choe et al.

Summary: By utilizing circuits that integrate recognition of multiple imperfect but complementary antigens, we have enhanced the specificity, completeness, and persistence of CAR T cells directed against glioblastoma, offering a general recognition strategy applicable to other solid tumors.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Cycling cancer persister cells arise from lineages with distinct programs

Yaara Oren et al.

Summary: Recent studies have revealed that cancer cells can enter different lineages in response to treatment, with distinct biological characteristics and metabolic programs. Proliferative capacity of drug-tolerant persister cells is associated with upregulation of antioxidant gene programs and a metabolic shift to fatty acid oxidation.

NATURE (2021)

Review Oncology

The 2021 WHO Classification of Tumors of the Central Nervous System: a summary

David N. Louis et al.

Summary: The fifth edition of the WHO Classification of Tumors of the Central Nervous System integrates molecular diagnostics into CNS tumor classification, introduces different approaches to tumor nomenclature and grading, and emphasizes the importance of integrated diagnoses and layered reports.

NEURO-ONCOLOGY (2021)

Article Oncology

Gradient of Developmental and Injury Response transcriptional states defines functional vulnerabilities underpinning glioblastoma heterogeneity

Laura M. Richards et al.

Summary: The study revealed that glioblastomas contain diverse cell populations, with GSCs showing high transcriptional heterogeneity associated with normal neural development and inflammatory wound response. Genome-wide CRISPR-Cas9 dropout screens validated this observation. Additionally, the majority of malignant cells were found to organize along an orthogonal astrocyte maturation gradient while retaining founder GSC transcriptional programs.

NATURE CANCER (2021)

Article Oncology

Single-cell analyses reveal YAP/TAZ as regulators of stemness and cell plasticity in glioblastoma

Martina Castellan et al.

Summary: The study identified YAP/TAZ coactivators as master regulators of GSCs in glioblastoma, essential for tumor maintenance. Their inhibition locks GBM cells into a non-tumorigenic state, preventing regeneration of GSC-like cells.

NATURE CANCER (2021)

Article Oncology

Pathway-based classification of glioblastoma uncovers a mitochondrial subtype with therapeutic vulnerabilities

Luciano Garofano et al.

Summary: Garofano et al. classified glioblastomas into subtypes along metabolic and neurodevelopmental axes using single-cell RNA-sequencing data. Mitochondrial GBM showed the most favorable clinical outcome and vulnerability to inhibitors of oxidative phosphorylation, while glycolytic/plurimetabolic GBM relied on aerobic glycolysis and other metabolic pathways for energy production. This pathway-based classification can inform survival and precision targeting of cancer metabolism.

NATURE CANCER (2021)

Article Cell & Tissue Engineering

Outer Radial Glia-like Cancer Stem Cells Contribute to Heterogeneity of Glioblastoma

Aparna Bhaduri et al.

CELL STEM CELL (2020)

Article Cell & Tissue Engineering

The Rational Development of CD133-Targeting Immunotherapies for Glioblastoma

Parvez Vora et al.

CELL STEM CELL (2020)

Article Multidisciplinary Sciences

Mechanisms and therapeutic implications of hypermutation in gliomas

Mehdi Touat et al.

NATURE (2020)

Review Biochemistry & Molecular Biology

Targeting the DNA Damage Response to Overcome Cancer Drug Resistance in Glioblastoma

Alessandra Ferri et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Medicine, Research & Experimental

Epigenetic modulator inhibition overcomes temozolomide chemoresistance and antagonizes tumor recurrence of glioblastoma

Byoung-San Moon et al.

JOURNAL OF CLINICAL INVESTIGATION (2020)

Review Biochemistry & Molecular Biology

Current Opinion on Molecular Characterization for GBM Classification in Guiding Clinical Diagnosis, Prognosis, and Therapy

Pei Zhang et al.

FRONTIERS IN MOLECULAR BIOSCIENCES (2020)

Article Multidisciplinary Sciences

High-resolution mouse subventricular zone stem-cell niche transcriptome reveals features of lineage, anatomy, and aging

Xuanhua P. Xie et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Multidisciplinary Sciences

Combined PI3Kα-mTOR Targeting of Glioma Stem Cells

Frank D. Eckerdt et al.

SCIENTIFIC REPORTS (2020)

Review Biochemistry & Molecular Biology

Emerging role of tumor cell plasticity in modifying therapeutic response

Siyuan Qin et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Review Immunology

A guide to cancer immunotherapy: from T cell basic science to clinical practice

Alex D. Waldman et al.

NATURE REVIEWS IMMUNOLOGY (2020)

Review Oncology

Glioblastoma Stem cells: Driving Resilience through Chaos

Briana C. Prager et al.

TRENDS IN CANCER (2020)

Review Clinical Neurology

The landscape of the mesenchymal signature in brain tumours

Jinan Behnan et al.

BRAIN (2019)

Article Biochemistry & Molecular Biology

Immune and genomic correlates of response to anti-PD-1 immunotherapy in glioblastoma

Junfei Zhao et al.

NATURE MEDICINE (2019)

Article Neurosciences

Cell-of-origin susceptibility to glioblastoma formation declines with neural lineage restriction

Sheila Alcantara Llaguno et al.

NATURE NEUROSCIENCE (2019)

Article Biochemistry & Molecular Biology

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma

Cyril Neftel et al.

Review Cell Biology

Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer

Ryan C. Gimple et al.

GENES & DEVELOPMENT (2019)

Review Clinical Neurology

Genetic and molecular epidemiology of adult diffuse glioma

Annette M. Molinaro et al.

NATURE REVIEWS NEUROLOGY (2019)

Article Cell Biology

Targeting pyrimidine synthesis accentuates molecular therapy response in glioblastoma stem cells

Xiuxing Wang et al.

SCIENCE TRANSLATIONAL MEDICINE (2019)

Article Multidisciplinary Sciences

BMP signaling mediates glioma stem cell quiescence and confers treatment resistance in glioblastoma

Rohit Sachdeva et al.

SCIENTIFIC REPORTS (2019)

Article Oncology

Genetic, Epigenetic, and Immunologic Profiling of MMR-Deficient Relapsed Glioblastoma

Stefano Indraccolo et al.

CLINICAL CANCER RESEARCH (2019)

Article Medicine, Research & Experimental

Osteopontin mediates glioblastoma-associated macrophage infiltration and is a potential therapeutic target

Jun Wei et al.

JOURNAL OF CLINICAL INVESTIGATION (2019)

Article Multidisciplinary Sciences

Developmental and oncogenic programs in H3K27M gliomas dissected by single-cell RNA-seq

Mariella G. Filbin et al.

SCIENCE (2018)

Article Multidisciplinary Sciences

Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles

Franz L. Ricklefs et al.

SCIENCE ADVANCES (2018)

Article Medicine, General & Internal

Combined Nivolumab and Ipilimumab in Melanoma Metastatic to the Brain

Hussein A. Tawbi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Article Multidisciplinary Sciences

Fate mapping of human glioblastoma reveals an invariant stem cell hierarchy

Xiaoyang Lan et al.

NATURE (2017)

Article Genetics & Heredity

Spatiotemporal genomic architecture informs precision oncology in glioblastoma

Jin-Ku Lee et al.

NATURE GENETICS (2017)

Article Biochemistry & Molecular Biology

Targeting glioma stem cells through combined BMI1 and EZH2 inhibition

Xun Jin et al.

NATURE MEDICINE (2017)

Article Multidisciplinary Sciences

Multiplexed RNAi therapy against brain tumor-initiating cells via lipopolymeric nanoparticle infusion delays glioblastoma progression

Dou Yu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)

Article Multidisciplinary Sciences

Decoupling genetics, lineages, and microenvironment in IDH-mutant gliomas by single-cell RNA-seq

Andrew S. Venteicher et al.

SCIENCE (2017)

Review Pathology

Characterization of gliomas: from morphology to molecules

Sean P. Ferris et al.

VIRCHOWS ARCHIV (2017)

Review Biotechnology & Applied Microbiology

DNA repair mechanisms and their clinical impact in glioblastoma

Helene Erasimus et al.

MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2016)

Article Multidisciplinary Sciences

Single-cell RNA-seq supports a developmental hierarchy in human oligodendroglioma

Itay Tirosh et al.

NATURE (2016)

Article Genetics & Heredity

Clonal evolution of glioblastoma under therapy

Jiguang Wang et al.

NATURE GENETICS (2016)

Article Oncology

Spatiotemporal Evolution of the Primary Glioblastoma Genome

Jinkuk Kim et al.

CANCER CELL (2015)

Article Oncology

Adult Lineage-Restricted CNS Progenitors Specify Distinct Glioblastoma Subtypes

Sheila R. Alcantara Llaguno et al.

CANCER CELL (2015)

Article Biochemistry & Molecular Biology

Single-Cell Transcriptome Analyses Reveal Signals to Activate Dormant Neural Stem Cells

Yuping Luo et al.

Article Oncology

Pyrvinium Targets CD133 in Human Glioblastoma Brain Tumor-Initiating Cells

Chitra Venugopal et al.

CLINICAL CANCER RESEARCH (2015)

Review Cell Biology

Cancer stem cells in glioblastoma

Justin D. Lathia et al.

GENES & DEVELOPMENT (2015)

Article Multidisciplinary Sciences

Single cell-derived clonal analysis of human glioblastoma links functional and genomic heterogeneity

Mona Meyer et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Cell & Tissue Engineering

EZH2 Protects Glioma Stem Cells from Radiation-Induced Cell Death in a MELK/FOXMI-Dependent Manner

Sung-Hak Kim et al.

STEM CELL REPORTS (2015)

Article Biochemistry & Molecular Biology

Conversion of differentiated cancer cells into cancer stem-like cells in a glioblastoma model after primary chemotherapy

B. Auffinger et al.

CELL DEATH AND DIFFERENTIATION (2014)

Article Multidisciplinary Sciences

Mutational Analysis Reveals the Origin and Therapy-Driven Evolution of Recurrent Glioma

Brett E. Johnson et al.

SCIENCE (2014)

Article Multidisciplinary Sciences

Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma

Anoop P. Patel et al.

SCIENCE (2014)

Article Biochemistry & Molecular Biology

The Somatic Genomic Landscape of Glioblastoma

Cameron W. Brennan et al.

Article Neurosciences

Brain tumor initiating cells adapt to restricted nutrition through preferential glucose uptake

William A. Flavahan et al.

NATURE NEUROSCIENCE (2013)

Article Multidisciplinary Sciences

Prominin 1/CD133 Endothelium Sustains Growth of Proneural Glioma

Bi-Sen Ding et al.

PLOS ONE (2013)

Article Multidisciplinary Sciences

Intratumor heterogeneity in human glioblastoma reflects cancer evolutionary dynamics

Andrea Sottoriva et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Cell & Tissue Engineering

CD133 Is Essential for Glioblastoma Stem Cell Maintenance

Paola Brescia et al.

STEM CELLS (2013)

Review Oncology

Unravelling cancer stem cell potential

Benjamin Beck et al.

NATURE REVIEWS CANCER (2013)

Article Oncology

Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty

Jeffrey A. Magee et al.

CANCER CELL (2012)

Article Biochemical Research Methods

CD90 is Identified as a Candidate Marker for Cancer Stem Cells in Primary High-Grade Gliomas Using Tissue Microarrays

Jintang He et al.

MOLECULAR & CELLULAR PROTEOMICS (2012)

Article Multidisciplinary Sciences

A restricted cell population propagates glioblastoma growth after chemotherapy

Jian Chen et al.

NATURE (2012)

Article Multidisciplinary Sciences

Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response

Nicholas J. Szerlip et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)

Article Medicine, General & Internal

On the origin of glioma

Yiwen Jiang et al.

UPSALA JOURNAL OF MEDICAL SCIENCES (2012)

Review Biochemistry & Molecular Biology

Chemoresistance of glioblastoma cancer stem cells - much more complex than expected

Dagmar Beier et al.

MOLECULAR CANCER (2011)

Article Multidisciplinary Sciences

Metabolic state of glioma stem cells and nontumorigenic cells

Erina Vlashi et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)

Article Oncology

Tumorigenic and Metastatic Activity of Human Thyroid Cancer Stem Cells

Matilde Todaro et al.

CANCER RESEARCH (2010)

Article Cell & Tissue Engineering

Integrin Alpha 6 Regulates Glioblastoma Stem Cells

Justin D. Lathia et al.

CELL STEM CELL (2010)

Article Cell & Tissue Engineering

Notch Promotes Radioresistance of Glioma Stem Cells

Jialiang Wang et al.

STEM CELLS (2010)

Article Cell & Tissue Engineering

SSEA-1 Is an Enrichment Marker for Tumor-Initiating Cells in Human Glioblastoma

Myung Jin Son et al.

CELL STEM CELL (2009)

Article Oncology

Comparative Analysis of DNA Repair in Stem and Nonstem Glioma Cell Cultures

Monica Ropolo et al.

MOLECULAR CANCER RESEARCH (2009)

Review Neurosciences

Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity

Akiko Nishiyama et al.

NATURE REVIEWS NEUROSCIENCE (2009)

Article Oncology

Temozolomide preferentially depletes cancer stem cells in glioblastoma

Dagmar Beier et al.

CANCER RESEARCH (2008)

Article Oncology

Targeting cancer stem cells through L1CAM suppresses glioma growth

Shideng Bao et al.

CANCER RESEARCH (2008)

Review Biochemistry & Molecular Biology

Mechanisms and functional implications of adult neurogenesis

Chunmei Zhao et al.

Review Oncology

Mechanisms of chemoresistance to alkylating agents in malignant glioma

Jann N. Sarkaria et al.

CLINICAL CANCER RESEARCH (2008)

Article Oncology

CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells

Jian Wang et al.

INTERNATIONAL JOURNAL OF CANCER (2008)

Review Cell Biology

Cancer stem cells in prostate adenocarcinoma: a target for new anticancer strategies

D. Fioriti et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2008)

Review Oncology

Gastric cancer stem cells

Shigeo Takaishi et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Medicine, Research & Experimental

Clinical and biological implications of CD133-positive and CD133-negative cells in glioblastomas

Kyeung Min Joo et al.

LABORATORY INVESTIGATION (2008)

Article Clinical Neurology

Identification of A2B5+CD133-tumor-initiating cells in adult human gliomas

Alfred T. Ogden et al.

NEUROSURGERY (2008)

Article Biochemistry & Molecular Biology

Identification and expansion of the tumorigenic lung cancer stem cell population

A. Eramo et al.

CELL DEATH AND DIFFERENTIATION (2008)

Article Cell & Tissue Engineering

Colon cancer stem cells dictate tumor growth and resist cell death by production of interleukin-4

Matilde Todaro et al.

CELL STEM CELL (2007)

Article Oncology

Making a tumour's bed: glioblastoma stem cells and the vascular niche

Richard J. Gilbertson et al.

NATURE REVIEWS CANCER (2007)

Review Biochemical Research Methods

Cancer stem cells in solid tumors

Laurie E. Ailles et al.

CURRENT OPINION IN BIOTECHNOLOGY (2007)

Article Gastroenterology & Hepatology

Identification and characterization of tumorigenic liver cancer stem/progenitor cells

Stephanie Ma et al.

GASTROENTEROLOGY (2007)

Article Biochemistry & Molecular Biology

HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity

Virginie Clement et al.

CURRENT BIOLOGY (2007)

Article Oncology

A perivascular niche for brain tumor stem cells

Christopher Calabrese et al.

CANCER CELL (2007)

Article Biochemistry & Molecular Biology

Analysis of gene expression and chemoresistance of CDI33+ cancer stem cells in glioblastoma

Gentao Liu et al.

MOLECULAR CANCER (2006)

Article Biochemistry & Molecular Biology

Chemotherapy resistance of glioblastoma stem cells

A. Eramo et al.

CELL DEATH AND DIFFERENTIATION (2006)

Review Medicine, General & Internal

Mechanisms of disease: Neural stem cells and the origin of gliomas

N Sanai et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

MGMT gene silencing and benefit from temozolomide in glioblastoma

ME Hegi et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Article Medicine, General & Internal

Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma

R Stupp et al.

NEW ENGLAND JOURNAL OF MEDICINE (2005)

Review Oncology

Stem cell origin of cancer and differentiation therapy

S Sell

CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2004)

Article Multidisciplinary Sciences

Identification of human brain tumour initiating cells

SK Singh et al.

NATURE (2004)

Article Biochemistry & Molecular Biology

Genetic alterations and in vivo tumorigenicity of neurospheres derived from an adult glioblastoma

Patrizia Tunici et al.

MOLECULAR CANCER (2004)

Article Multidisciplinary Sciences

Cancerous stem cells can arise from pediatric brain tumors

HD Hemmati et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Multidisciplinary Sciences

Prospective identification of tumorigenic breast cancer cells

M Al-Hajj et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Neurosciences

Identification of neural stem cells in the adult vertebrate brain

A Alvarez-Buylla et al.

BRAIN RESEARCH BULLETIN (2002)

Article Neurosciences

Isolation of multipotent neural precursors residing in the cortex of the adult human brain

Y Arsenijevic et al.

EXPERIMENTAL NEUROLOGY (2001)